397 patients who were 18 — 65 years of age, had a diagnosis of schizophrenia or
schizoaffective disorder according to DSM - IV criteria, had required intensive psychiatric treatment within 24 months before study entry, had received a stable dose of antipsychotic medication for ≥ 30 days before study entry, had resided at the same address for ≥ 30 days before study entry, and were judged clinically stable by the principal investigator.
Not exact matches
According to clinical judgement, participants were excluded if they suffered from severe depression (≥ 7 criteria, including main symptoms), severe anxiety
disorder, bipolar
disorder,
schizoaffective disorder, severe psychiatric and psychotic conditions, substance abuse, suicidal ideation or if they exhibited low - German language and / or computer skills.
Patients had to fulfil the following criteria: a diagnosis of schizophrenia,
schizoaffective psychosis, or delusional
disorder according to criteria from the Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised11; no evidence of organic brain disease; substance abuse not identified as the primary problem; age between 18 and 65 years; presence of persistent hallucinations or delusions, or both, for a minimum of 6 months and at least 1 month of stabilisation if they had experienced an exacerbation during this period; stable medication; no psychological or family intervention; their responsible medical officer had given permission for them to enter the study; no serious threat of violence towards the assessors; and they had given informed consent to participate.
87 patients who were 18 — 65 years of age and had a diagnosis of schizophrenia,
schizoaffective psychosis, or delusional
disorder according to the DSM - III - R; hallucinations or delusions for ≥ 6 months; were receiving of stable medication; and had permission from the responsible physician to participate.